发明名称 |
MUTANTS OF HUMAN INTERLEUKIN-3 |
摘要 |
Mutants of hIL-3 are provided having deletions covering virtually the complete coding region of hIL-3, while retaining their biological activity. Preferred mutants are those having one or more deletions at the N-terminus (amino acids 1-14) and/or the C-terminus (amino acids 116-133, 120- 130 and/or 130-133). Another preferred group of mutants are substitution mutants. Some of these mutants have an antagonistic effect. Specific examples are Cys -> Ala mutants (Cys16 -> Ala16, Cys16Cys84 -> Ala16Ala84). Other mutants having an antagonistic effect are Glu50 -> Lys50 and Lys79 -> Glu79. Finally antibodies are provided aimed at specific epitopes localized between amino acids 29 and 54.
|
申请公布号 |
CA2023246(C) |
申请公布日期 |
2002.02.19 |
申请号 |
CA19902023246 |
申请日期 |
1990.08.14 |
申请人 |
DORSSERS, LAMBERTUS C. J.;VAN LEEN, ROBERT W. |
发明人 |
DORSSERS, LAMBERTUS C. J.;VAN LEEN, ROBERT W. |
分类号 |
C12N15/09;A61K38/00;A61K38/18;A61K38/19;A61K38/20;A61K39/395;A61P3/02;A61P7/00;A61P35/00;A61P37/00;A61P43/00;C07K;C07K14/00;C07K14/005;C07K14/195;C07K14/52;C07K14/53;C07K14/54;C07K16/00;C07K16/24;C12N;C12N1/21;C12N5/10;C12N15/24;C12N15/27;C12P21/02;C12P21/08;C12R1/07;C12R1/19;(IPC1-7):C12N15/24 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|